Spain – Various medicinal products – Suministro del principio activo INCLISIRAN 248 mg jeringa precargada subcutánea
Dirección Gerencia del Complejo Hospitalario Universitario de Canarias awarded €323K to NOVARTIS FARMACÉUTICA S.A. for Construction & Public Works in March 2026 — one of 28 awards this buyer has made, in line with its typical award size.
Winning supplier
NOVARTIS FARMACÉUTICA S.A.Contract description
Spain – Various medicinal products – Suministro del principio activo INCLISIRAN 248 mg jeringa precargada subcutánea
Related awards · Dirección Gerencia del Complejo Hospitalario Universitario de Canarias
28 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-699132-2025GILEAD SCIENCES S.L.€614K23 Oct 2025 Construction
- ocds-ted-134672-2024ViiV HEALTHCARE, S.L.€606K05 Mar 2024 Construction
- ocds-ted-348049-2024FCC CONSTRUCCIÓN, S.A. (A-28854727) en compromiso de UTE con FCC INDUSTRIAL E INFRAESTRUCTURAS ENERGÉTICAS, S.A.U. (A-28482024)€531K12 Jun 2024 Construction
Other wins · NOVARTIS FARMACÉUTICA S.A.
177 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerencia del Complejo Hospitalario Universitario de Canarias and NOVARTIS FARMACÉUTICA S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back